Education
About Us
Working with TipRanks
Follow Us
Michael Stewart Lee Insider Profile
4 Followers
Michael Stewart Lee, Director at Fate Therapeutics, holds 11.06K shares in IGM Biosciences (Ticker: IGMS), holds 11.33K shares in Fate Therapeutics (Ticker: FATE), holds ― shares in Shattuck Labs (Ticker: STTK).
Michael Stewart Lee has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Michael Stewart Lee holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Michael Stewart Lee
Michael Stewart Lee's Trading History
Fate Therapeutics
Jun 13, 2022
Director
Uninformative Buy
―
$11.44K
IGM Biosciences
Jan 02, 2025
Director
Uninformative Buy
―
$14.59K
Shattuck Labs
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Michael Stewart Lee's performance on stock
You May Also Like
Michael Stewart Lee insider profile FAQ
What is the percentage of profitable transactions made by Michael Stewart Lee?
The percentage of profitable transactions made by Michael Stewart Lee is ―.
What is the average return per transaction made by Michael Stewart Lee?
The average return per transaction made by Michael Stewart Lee is ―.
What stocks does Michael Stewart Lee hold?
Michael Stewart Lee holds: FATE, IGMS, STTK stocks.
What was Michael Stewart Lee’s latest transaction?
Michael Stewart Lee latest transaction was an Uninformative Buy of ―.
What was Michael Stewart Lee's most profitable transaction?
Michael Stewart Lee’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Michael Stewart Lee's role in Fate Therapeutics?
Michael Stewart Lee's role in Fate Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.